Table 8 miRNA expression in the blood of patients with different clinical T-stage, Gleason score, and metastatic status

Clinical T-stage

  ≤ 2

0.73 (0.40,1.06)

0.54 (0.43,0.59)

0.84 (0.75,0.96)

0.87 (0.83,1.00)

  > 2

1.00 (0.65,2.31)

0.56(0.35,0.62)

0.91 (0.78,1.02)

0.80 (0.63,0.95)

 Z

 − 1.665

 − 0.333

 − 0.916

 − 1.498

 P

0.096

0.739

0.360

0.134

Gleason score

  ≤ 7

0.91 (0.44,1.29)

0.54 (0.42,0.57)

0.79 (0.88,0.96)

0.88 ± 0.06

  > 7

0.80 (0.48,1.36)

0.56 (0.45,0.63)

0.89 (0.77,0.98)

0.93 ± 0.29

 Z/t

 − 0.547

 − 1.300

 − 0.684

 − 0.650

 P

0.584

0.194

0.494

0.518

metastatic status

 No

0.90 (0.33,1.34)

0.54 (0.42,0.65)

0.82 (0.71,0.95)

0.86 (0.79,0.95)

 Yes

0.80 (0.68,1.35)

0.56 (0.42,0.58)

0.96 (0.82,0.99)

0.87 (0.76,1.06)

 Z

 − 0.423

 − 0.962

 − 1.347

 − 0.038

 P

0.672

0.336

0.178

0.969